Literature DB >> 20461405

Hidden hazards of HCV transmission.

Robério Amorim de Almeida Pondé1.   

Abstract

Hepatitis C virus infection is a global health problem that has important epidemiological and clinical consequences. It has been well established that exposure to infected blood is the main risk factor for HCV transmission. However, in 20% of cases the agent transmission occurs by unknown route or in the presence of an unidentified source of infection. Understanding of the epidemiology of HCV is needed to help us define future control and preventive strategies. Herein, we discuss about diagnosis of HCV infection and hepatitis C surveillance in the context of its transmission.

Entities:  

Mesh：

Year:  2010        PMID： 20461405     DOI： 10.1007/s00430-010-0159-9

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  50 in total

1.  Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

Authors:  E L Murphy; S M Bryzman; S A Glynn; D I Ameti; R A Thomson; A E Williams; C C Nass; H E Ownby; G B Schreiber; F Kong; K R Neal; G J Nemo
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Nosocomial transmission of HCV in the liver unit of a tertiary care center.

Authors:  Xavier Forns; Eva Martínez-Bauer; Anna Feliu; Montserrat García-Retortillo; Marta Martín; Eugeni Gay; Miquel Navasa; Jose Maria Sánchez-Tapias; Miquel Bruguera; Juan Rodés
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

Review 3.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 4.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

5.  Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres.

Authors:  Evangelista Sagnelli; Nicola Coppola; Cecilia Marrocco; Giancarlo Coviello; Martina Battaglia; Vincenzo Messina; Giovanni Rossi; Caterina Sagnelli; Carlo Scolastico; Pietro Filippini
Journal:  J Hepatol       Date:  2005-05       Impact factor: 25.083

6.  Nosocomial hepatitis C in a thoracic surgery unit; retrospective findings generating a prospective study.

Authors:  K Cardell; A Widell; A Frydén; B Akerlind; A-S Månsson; S Franzén; U-B Lymer; B Isaksson
Journal:  J Hosp Infect       Date:  2008-02-21       Impact factor: 3.926

7.  Surveillance for acute viral hepatitis--United States, 2006.

Authors:  Annemarie Wasley; Scott Grytdal; Kathleen Gallagher
Journal:  MMWR Surveill Summ       Date:  2008-03-21

8.  [Hepatitis C virus. Iatrogenic and nosocomial transmition?].

Authors:  Francisca Monsalve-Castillo; Liliana Gómez-Gamboa
Journal:  Invest Clin       Date:  2004-09       Impact factor: 0.683

Review 9.  Health care worker-to-patient transmission of hepatitis C virus in the health care setting: Many questions and few answers.

Authors:  Reinhard B Raggam; Angelika M Rossmann; Helmut J F Salzer; Rudolf E Stauber; Harald H Kessler
Journal:  J Clin Virol       Date:  2009-05-28       Impact factor: 3.168

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962
View more
  14 in total

Review 1.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

Review 2.  Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-11       Impact factor: 3.267

3.  Risk factors for hepatitis C virus transmission obscure in nigerian patients.

Authors:  Olive Obienu; Sylvester Nwokediuko; Abraham Malu; Olufunmilayo A Lesi
Journal:  Gastroenterol Res Pract       Date:  2011-07-13       Impact factor: 2.260

Review 4.  Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis.

Authors:  Monica Alonso; Annika Gutzman; Rafael Mazin; Carlos E Pinzon; Ludovic Reveiz; Massimo Ghidinelli
Journal:  Int J Public Health       Date:  2015-08-23       Impact factor: 3.380

Review 5.  Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review.

Authors:  Viktor Mravčík; Lisa Strada; Josef Stolfa; Vladimir Bencko; Teodora Groshkova; Jens Reimer; Bernd Schulte
Journal:  Patient Prefer Adherence       Date:  2013-10-17       Impact factor: 2.711

6.  Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains.

Authors:  Xia Rong; Ling Lu; Junzhi Wang; Huaping Xiong; Jieting Huang; Jinyan Chen; Ke Huang; Ru Xu; Min Wang; Xuemei Zhang; Tai Guo; Yueyue Liu; Guoquan Gao; Yongshui Fu; Kenrad E Nelson
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

7.  Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati.

Authors:  G L Abby Harrison; Jan Pryor; Joji Malani; Mathias Supuri; Andrew Masta; Burentau Teriboriki; Tebuka Toatu; David Penny; Jean-Pierre Allain; Eleanor Barnes; Oliver G Pybus; Paul Klenerman
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

8.  Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.

Authors:  Lisa Strada; Bernd Schulte; Christiane Sybille Schmidt; Uwe Verthein; Peter Cremer-Schaeffer; Sabine Krückeberg; Jens Reimer
Journal:  BMC Infect Dis       Date:  2015-12-10       Impact factor: 3.090

9.  Biomedical Mutation Analysis (BMA): A software tool for analyzing mutations associated with antiviral resistance.

Authors:  Karina Salvatierra; Hector Florez
Journal:  F1000Res       Date:  2016-06-03

Review 10.  Aspects on the history of transmission and favor of distribution of viruses by iatrogenic action: perhaps an example of a paradigm of the worldwide spread of HIV.

Authors:  Lutz G Gürtler; Josef Eberle
Journal:  Med Microbiol Immunol       Date:  2017-04-22       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.